Assessing therapeutic decisions in generalized myasthenia gravis: Study protocol.

ABSTRACT:

Background

The therapeutic landscape in generalized myasthenia gravis (gMG) has been continuously evolving in recent years, with over five products approved, each with different efficacy, safety, and administration profiles. With the availability of new targeted treatments, physicians are faced with the challenge of therapeutic decision-making tailored to traditional therapeutic goals, individual preferences, and personal experience, seeking optimal disease control with a positive safety profile. In this context of uncertainty and multiple novel choices, this study aims to provide insights into the preferred treatment choices of neurologists managing gMG and to identify demographic, professional or behavioral factors influencing the decision-making process.

Methods

This is a

SUBMITTER: Gutierrez-Gutierrez G 

PROVIDER: S-EPMC12013924 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature